Literature DB >> 10196383

Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21.

D Hernandez1, P J Mee, J E Martin, V L Tybulewicz, E M Fisher.   

Abstract

At least 8% of all human conceptions have major chromosome abnormalities and the frequency of chromosomal syndromes in newborns is >0.5%. Despite these disorders making a large contribution to human morbidity and mortality, we have little understanding of their aetiology and little molecular data on the importance of gene dosage to mammalian cells. Trisomy 21, which results in Down syndrome (DS), is the most frequent aneuploidy in humans (1 in 600 live births, up to 1 in 150 pregnancies world-wide) and is the most common known genetic cause of mental retardation. To investigate the molecular genetics of DS, we report here the creation of mice that carry different human chromosome 21 (Hsa21) fragments as a freely segregating extra chromosome. To produce these 'transchromosomal' animals, we placed a selectable marker into Hsa21 and transferred the chromosome from a human somatic cell line into mouse embryonic stem (ES) cells using irradiation microcell-mediated chromosome transfer (XMMCT). 'Transchromosomal' ES cells containing different Hsa21 regions ranging in size from approximately 50 to approximately 0.2 Mb have been used to create chimeric mice. These mice maintain Hsa21 sequences and express Hsa21 genes in multiple tissues. This novel use of the XMMCT protocol is applicable to investigations requiring the transfer of large chromosomal regions into ES or other cells and, in particular, the modelling of DS and other human aneuploidy syndromes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196383     DOI: 10.1093/hmg/8.5.923

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  22 in total

Review 1.  Microcell-mediated chromosome transfer (MMCT): small cells with huge potential.

Authors:  Aideen M O Doherty; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

2.  Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies.

Authors:  K Tomizuka; T Shinohara; H Yoshida; H Uejima; A Ohguma; S Tanaka; K Sato; M Oshimura; I Ishida
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  Artificial chromosome-based transgenes in the study of genome function.

Authors:  Jason D Heaney; Sarah K Bronson
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

Review 4.  Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Authors:  Narumi Uno; Satoshi Abe; Mitsuo Oshimura; Yasuhiro Kazuki
Journal:  J Hum Genet       Date:  2017-11-27       Impact factor: 3.172

Review 5.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

6.  Efficient male and female germline transmission of a human chromosomal vector in mice.

Authors:  T Voet; J Vermeesch; A Carens; J Dürr; C Labaere; H Duhamel; G David; P Marynen
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

7.  Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.

Authors:  E-Chiang Lee; Qi Liang; Hanif Ali; Luke Bayliss; Alastair Beasley; Tara Bloomfield-Gerdes; Laura Bonoli; Richard Brown; Jamie Campbell; Adam Carpenter; Sara Chalk; Alison Davis; Nick England; Alla Fane-Dremucheva; Bettina Franz; Volker Germaschewski; Helen Holmes; Steve Holmes; Ian Kirby; Miha Kosmac; Anais Legent; Hui Lui; Anais Manin; Siobhan O'Leary; Jemima Paterson; Rocco Sciarrillo; Anneliese Speak; Dominik Spensberger; Laura Tuffery; Nikole Waddell; Wei Wang; Sophie Wells; Vivian Wong; Andrew Wood; Michael J Owen; Glenn A Friedrich; Allan Bradley
Journal:  Nat Biotechnol       Date:  2014-03-16       Impact factor: 54.908

Review 8.  Mouse models for Down syndrome-associated developmental cognitive disabilities.

Authors:  Chunhong Liu; Pavel V Belichenko; Li Zhang; Dawei Fu; Alexander M Kleschevnikov; Antonio Baldini; Stylianos E Antonarakis; William C Mobley; Y Eugene Yu
Journal:  Dev Neurosci       Date:  2011-08-25       Impact factor: 2.984

Review 9.  The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer.

Authors:  Karen J Meaburn; Christopher N Parris; Joanna M Bridger
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

10.  Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix.

Authors:  Frédéric Delom; Emma Burt; Alex Hoischen; Joris Veltman; Jürgen Groet; Finbarr E Cotter; Dean Nizetic
Journal:  Proteome Sci       Date:  2009-08-28       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.